SCHX vs XBI
Schwab US Large-Cap ETF vs SPDR S&P Biotech ETF
SCHX$29.98
Schwab US Large-Cap ETF
Low-cost US large-cap exposure.
Expense: 0.03%Yield: 1.05%
XBI$156.41
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.35%
Quick take
- • SCHX has the lower expense ratio at 0.03% vs 0.35% for XBI.
- • SCHX pays a higher dividend yield (1.05%).
Side-by-side metrics
| Metric | SCHX | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.05% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $73.24B | $10.92B |
YTD return | 11.01% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.99 | 1.01 |
P/E ratio | 23.63 | — |
Last price | $29.98 | $156.41 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHX top holdings
Top holdings · SCHX
| AAPL | Apple Inc | 7.27% |
| NVDA | NVIDIA Corp | 7.16% |
| MSFT | Microsoft Corp | 5.60% |
| AMZN | Amazon.com Inc | 3.41% |
| GOOGL | Alphabet Inc Class A | 2.37% |
| AVGO | Broadcom Inc | 2.24% |
| META | Meta Platforms Inc Class A | 1.96% |
| GOOG | Alphabet Inc Class C | 1.91% |
| LLY | Eli Lilly and Co | 1.64% |
| TSLA | Tesla Inc | 1.63% |
Sector breakdown · SCHX
Real Estate1.9%
Consumer Cyclical9.1%
Basic Materials1.7%
Consumer Defensive4.8%
Technology37.5%
Communication Services8.1%
Financial Services12.0%
Utilities2.0%
Industrials8.5%
Energy4.0%
Healthcare10.4%
XBI top holdings
Top holdings · XBI
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%
About SCHX
SCHX (Schwab US Large-Cap ETF) is Low-cost US large-cap exposure. Managed by Schwab, the fund carries $73.2B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.05%. Its largest holding is Apple Inc (AAPL), which represents 7.3% of the portfolio. Real Estate is the fund's largest sector exposure at 1.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.